News
Abstract and Introduction Abstract Background: The clinical trial safety database for tiotropium has been augmented with a 4-year trial in patients with COPD, which provides an opportunity to ...
The powder version is Spiriva HandiHaler and the spray version Spiriva Respimat. Tiotropium bromide is a bronchodilator, or substance that relaxes airway muscles so they can widen. Widening air ...
"We are very pleased to partner with SUP to bring Tiotropium DPI to patients in China," said Fabrice Egros, President of Corporate Development at Lupin. "This partnership demonstrates our commitment ...
Pharma major Lupin Ltd on Monday said it has signed a license and supply agreement with China's Sino Universal Pharmaceuticals for the commercialisation of Tiotropium dry powder inhaler in the Chinese ...
Lupin Limited partners with Sino Universal Pharmaceuticals. They will commercialize Tiotropium dry powder inhaler in China. This inhaler treats Chronic Obstructive Pulmonary Disease. Sino Universal ...
Tiotropium DPI is known for its efficacy in improving lung function and quality of life for patients suffering from respiratory conditions. This partnership will enable Lupin to expand its footprint ...
Global pharma major Lupin Limited (Lupin) announced that it has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP), for the commercialization of tiotropium dry powder ...
Lupin has signed a licensing deal with China’s Sino Universal Pharmaceuticals to bring its Tiotropium inhaler to the Chinese market. The product, used for treating COPD, will be manufactured by ...
The company has entered into a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for the commercialization of Tiotropium Dry Powder Inhaler (DPI), 18 mcg/capsule.
Long-acting Anticholinergic Drugs in Asthma Tiotropium is the first long-acting anticholinergic drug that has been developed in the early 1990s and approved for the management of stable COPD. [102 ...
NEW DELHI, June 16: Pharma major Lupin Ltd on Monday said it has signed a license and supply agreement with China’s Sino Universal Pharmaceuticals for the commercialisation of Tiotropium dry powder ...
Background QVA149 is a once-daily (o.d.) inhaled dual bronchodilator containing a fixed-dose combination of the long-acting β2-agonist indacaterol and the long-acting muscarinic antagonist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results